Thomas Strüngmann (born 1950) is a German billionaire

investor An investor is a person who allocates financial capital with the expectation of a future Return on capital, return (profit) or to gain an advantage (interest). Through this allocated capital the investor usually purchases some species of pr ...

businessman A businessperson, also referred to as a businessman or businesswoman, is an individual who has founded, owns, or holds shares in (including as an angel investor) a private-sector company. A businessperson undertakes activities (commercial ...

, and entrepreneur. He has built his fortunes with his life-long partner and

identical twin Twins are two offspring produced by the same pregnancy.MedicineNet > Definition of Twin Last Editorial Review: 19 June 2000 Twins can be either ''monozygotic'' ('identical'), meaning that they develop from one zygote, which splits and forms two ...

Andreas Strüngmann Andreas Strüngmann (born 1950) is a German physician and billionaire businessman who founded generic drug maker Hexal AG ($1.6 billion sales during 2004) in 1986 and has built his fortunes, with his life-long partner and identical twin, Thomas ...

, mainly through his success in the

biotechnology Biotechnology is a multidisciplinary field that involves the integration of natural sciences and Engineering Science, engineering sciences in order to achieve the application of organisms and parts thereof for products and services. Specialists ...

and

pharmaceutical Medication (also called medicament, medicine, pharmaceutical drug, medicinal product, medicinal drug or simply drug) is a drug used to diagnose, cure, treat, or prevent disease. Drug therapy ( pharmacotherapy) is an important part of the ...

sectors. Based at his single

family office A family office is a privately held company that handles investment management and wealth management for a wealthy family, generally one with at least $50–100 million in investable assets, with the goal being to effectively grow and transfer ...

, Athos KG, Thomas manages, together with his brother, their total family assets expected to be worth roughly $30 billion, which positions the brothers among the wealthiest Germans.

Career

In 2004, Strüngmann and his twin brother

Andreas Andreas () is a name derived from the Greek noun ἀνήρ ''anēr'', with genitive ἀνδρός ''andros'', which means "man". See the article on Andrew for more information. The Scandinavian name is earliest attested as antreos in a runeston ...

– through their Santo Holding – acquired a share of 89.6 percent in Südwestbank from

DZ Bank DZ Bank AG () is the second largest bank in Germany by asset size and the central institution for around 700 cooperative banks and their around 7,200 branch offices. Within that Bundesverband der Deutschen Volksbanken und Raiffeisenbanken, w ...

. In 2017, they sold the bank for an undisclosed price to

BAWAG BAWAG (Abbreviation of , , ) was a bank in Austria founded in 1922. On October 1, 2005, it merged with the separate ''Österreichische Postsparkasse'' (P.S.K.) to form the "Bank für Arbeit und Wirtschaft und Österreichische Postsparkasse AG", s ...

. In 2005, the Strüngmann brothers sold Hexal to

Novartis Novartis AG is a Swiss multinational corporation, multinational pharmaceutical company, pharmaceutical corporation based in Basel, Switzerland. Novartis is one of the largest pharmaceutical companies in the world and was the eighth largest by re ...

for $6.7 billion. After the sale, he joined Novartis subsidiary

Sandoz Sandoz Group AG is a Swiss company that focuses on generic pharmaceuticals and biosimilars. Prior to October 2023, it was part of a division of Novartis that was established in 2003, when Novartis united all of its generics businesses under the ...

as head of regional operations in Germany, the Americas and the Middle East, reporting to Sandoz's chief executive, Andreas Rummelt. In 2008, the Strüngmann brothers – through their asset management firm Athos – agreed to underwrite 25 percent of a capital increase at Conergy. Also in 2008, the Strüngmann brothers supported

BioNTech BioNTech SE ( ; or short for Biopharmaceutical New Technologies) is a German multinational biotechnology company headquartered in Mainz that develops immunotherapies and vaccines, particularly for cancer and infectious diseases. The compan ...

with a €136.5 million seed investment in a €150 million round that enabled the founding of the company. They earned $8 billion on their stake in BioNTech. They own approximately 50 percent of the company as well as significant ownership in 4SC and Immatics. He currently has the largest health-care earned fortune with his brother. In 2014, the Strüngmann brothers' Santo Holding and

EQT AB EQT AB is a Swedish global investment organization founded in 1994. Its funds invest in private equity (EQT Private Capital Europe & North America), infrastructure (EQT Infrastructure), real estate (EQT Real Estate), growth equity, and ventur ...

purchased Siemens Audiology Solutions from

Siemens Siemens AG ( ) is a German multinational technology conglomerate. It is focused on industrial automation, building automation, rail transport and health technology. Siemens is the largest engineering company in Europe, and holds the positi ...

for €2.2 billion, leading the latter to abandon plans for an

initial public offering An initial public offering (IPO) or stock launch is a public offering in which shares of a company are sold to institutional investors and usually also to retail (individual) investors. An IPO is typically underwritten by one or more investm ...

.Christopher Hughes and Olaf Storbeck (25 November 2014)
SIG Deal Shows Private Equity’s Desire for Big Leveraged Buyouts in Europe
''

New York Times ''The New York Times'' (''NYT'') is an American daily newspaper based in New York City. ''The New York Times'' covers domestic, national, and international news, and publishes opinion pieces, investigative reports, and reviews. As one of ...

''. The brothers operate out of a family office, Athos Service.

References

External links

Forbes World's Richest People
1950 births Living people German billionaires 20th-century German businesspeople 21st-century German businesspeople {{Germany-business-bio-stub

Career

See also

References

External links